Comments
Loading...

Sonnet BioTherapeutics

SONNNASDAQ
Logo brought to you by Benzinga Data
$1.04
0.044.00%
At Close: -
$1.05
0.010.96%
After Hours: 6:13 PM EDT
15 minutes delayed

Sonnet BioTherapeutics (NASDAQ:SONN) Stock Quotes, Forecast and News Summary

Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.

Open$1.01
Close$1.04
Volume / Avg.72.32K / 140.50K
Day Range$1.01 - $1.09
52 Wk Range0.62 - 3.67
Market Cap$5.46M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
71
Short Interest
0.87%
Days to Cover1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Sonnet BioTherapeutics Holdings Inc
Sector
Health Care
Industry
Biotechnology
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has devel...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SONN
ALZN

FAQ

Q

How do I buy Sonnet BioTherapeutics (SONN) stock?

A

You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sonnet BioTherapeutics (SONN) competitors?

Q

What is the forecast, or price target, for Sonnet BioTherapeutics (SONN) stock?

A

Sonnet BioTherapeutics has a consensus price target of $9.12.

Q

What is the current price for Sonnet BioTherapeutics (SONN)?

A

The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.05 last updated September 19, 2024 at 6:13 PM EDT.

Q

Does Sonnet BioTherapeutics (SONN) pay a dividend?

A

There are no upcoming dividends for Sonnet BioTherapeutics.

Q

When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?

A

Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 12, 2024.

Q

Is Sonnet BioTherapeutics (SONN) going to split?

A

There is no upcoming split for Sonnet BioTherapeutics.

Q

What sector and industry does Sonnet BioTherapeutics (SONN) operate in?

A

Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch